The importance of trust between Patient and Oncologist

Doctor trustTrust is an important part of every relationship between healthcare professionals and patients and this can sometimes be challenging for those with NETs who have been misdiagnosed for many years.

When Theresa Wittenberg, a PA, noticed that many of the patients who had neuroendocrine tumors (NETs) were struggling to establish trust in their physicians, she recommended her team take a closer look. FIrst-year oncology fellow Eric Mou, MD, led the charge and visited a community support group to have an open conversation with patients living with this uncommon type of cancer. The experience impacted him so much he came back to his colleagues and said, "This has to be part of the curriculum for every fellow."

Read introduction by Stanford Medicine here

Read article published in Jama Oncology by Eric Mou here

 

Share this article

Subscribe to our Newsletter

Stay up to date on news and events, clinical trials and new research on neuroendocrine cancers.

Related News

Bringing Together Experts to Improve NET Patient Care: NECA at the 5th NET Preceptorship

NECA at ENETS 2025: Advancing NET Care on the Global Stage

The Australian Cancer Plan

Impact of Nutritional Status on Gastroenteropancreatic Neuroendocrine Tumors (GEP-NET) Aggressiveness

Walk, run, or ride this March4NETs!

For its third year, March4NETs will run throughout March 2026.

Get involved and support the 31,000 Australians living with neuroendocrine cancer.